Fierce Pharma: Reputation A Top Priority When Picking Prescription Meds

Prescription paper and pills | We. Communications

A Pharma company's reputation Ranked As A Leading Factor in Physician Prescription Decisions, According to We.'s Latest Healthy reputation: More Than Medicine Report

Fierce Pharma, Jacqueline Renfrow, 1 March 2023

In “Healthy Reputation: More Than Medicine,” healthcare professionals displayed their desire for pharma to go beyond just functional characteristics of a medication to address the entire health experience. In an interview with Fierce Pharma, Stephanie Marchesi, President, Global Health shared findings from We.'s latest report. 

“As communicators, our instincts and anecdotal feedback have told us that corporate reputation is important. But now we have hard evidence of its impact, both as influencing prescribing decisions among HCPs as well as contributing to the bottom line for biotech and pharma companies,” explained Marchesi.

To learn more, read We.'s latest Brands in Motion Report "Healthy Reputation: More Than Medicine."

 

   Full Article

 

(Photo courtesy of Fierce Pharma - Getty/LIgorko)

Explore more

Stephanie Marchesi named EMEA president | We. Communications

PRWeek: We. Communications Names EMEA President

Gretchen Ramsey and Kristen Jordan-Poinsette headshots | We. Communications

We. at Fierce Pharma PR & Comms Summit 2024

Jasmin Athwal and Danile Blank headshots | We. Communications

PRovoke: We. Communications Creates New EMEA Leadership Roles

We. launches Reputation Forecast | We. Communications

We. Communications Launches Reputation Forecast: A Board-Level Framework for Managing Reputation Value and Risk

Panel of speakers on stage | We. Communications

PRovoke: AI's Impact on PR "We're Not Doomed Immediately"

Laura Gillen headshot | We. Communications

PRWeek: We. Communications Names New UK Managing Director